These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2350626

  • 1. In vitro evaluation of combination drug purging for autologous bone marrow transplantation.
    Jones RJ, Miller CB, Zehnbauer BA, Rowley SD, Colvin OM, Sensenbrenner LL.
    Bone Marrow Transplant; 1990 May; 5(5):301-7. PubMed ID: 2350626
    [Abstract] [Full Text] [Related]

  • 2. Predictive value of colony-forming unit assays for engraftment and leukemia-free survival after transplantation of chemopurged syngeneic bone marrow in rats.
    Wiley JM, Yeager AM.
    Exp Hematol; 1991 Mar; 19(3):179-84. PubMed ID: 1704843
    [Abstract] [Full Text] [Related]

  • 3. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
    Peters RH, Brandon CS, Avila LA, Gale GR, Stuart RK.
    Prog Clin Biol Res; 1990 Mar; 333():57-68. PubMed ID: 2309001
    [Abstract] [Full Text] [Related]

  • 4. Prediction of the ability to purge tumor from murine bone marrow using clonogenic assays.
    Jones RJ, Colvin OM, Sensenbrenner LL.
    Cancer Res; 1988 Jun 15; 48(12):3394-7. PubMed ID: 3285994
    [Abstract] [Full Text] [Related]

  • 5. Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic study.
    Miller G, Brashear T, Stone M, Fay J.
    Int J Cell Cloning; 1991 Sep 15; 9(5):503-10. PubMed ID: 1955738
    [Abstract] [Full Text] [Related]

  • 6. Photoradiation methods for purging autologous bone marrow grafts.
    Gulati S, Atzpodien J, Lemoli RM, Shimazaki C, Clarkson B.
    Prog Clin Biol Res; 1990 Sep 15; 333():87-102. PubMed ID: 2137934
    [Abstract] [Full Text] [Related]

  • 7. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Lemoli RM, Gulati SC.
    Exp Hematol; 1990 Oct 15; 18(9):1008-12. PubMed ID: 2397748
    [Abstract] [Full Text] [Related]

  • 8. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS, Sikic BI, Blume KG, Chao NJ.
    Exp Hematol; 1992 Oct 15; 20(9):1048-54. PubMed ID: 1468539
    [Abstract] [Full Text] [Related]

  • 9. Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis.
    Chang TT, Gulati SC, Chou TC, Vega R, Gandola L, Ibrahim SM, Yopp J, Colvin M, Clarkson BD.
    Cancer Res; 1985 Jun 15; 45(6):2434-9. PubMed ID: 3857119
    [Abstract] [Full Text] [Related]

  • 10. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul 15; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 11. Purging with 4-hydroperoxycyclophosphamide combinations.
    Jones RJ, Miller CB, Rowley SD.
    Prog Clin Biol Res; 1992 Jul 15; 377():1-9; discussion 10-1. PubMed ID: 1438406
    [No Abstract] [Full Text] [Related]

  • 12. Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow.
    Chao NJ, Aihara M, Blume KG, Sikic BI.
    Exp Hematol; 1990 Dec 15; 18(11):1193-8. PubMed ID: 2226679
    [Abstract] [Full Text] [Related]

  • 13. Phase I study of combination drug purging for autologous bone marrow transplantation.
    Rowley SD, Miller CB, Piantadosi S, Davis JM, Santos GW, Jones RJ.
    J Clin Oncol; 1991 Dec 15; 9(12):2210-8. PubMed ID: 1960561
    [Abstract] [Full Text] [Related]

  • 14. Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation.
    Morecki S, Slavin S.
    Isr J Med Sci; 1988 Dec 15; 24(9-10):488-93. PubMed ID: 3060442
    [Abstract] [Full Text] [Related]

  • 15. Effects of verapamil on etoposide, vincristine, and adriamycin activity in normal human bone marrow granulocyte-macrophage progenitors and in human K562 leukemia cells in vitro.
    Yalowich JC, Zucali JR, Gross M, Ross WE.
    Cancer Res; 1985 Oct 15; 45(10):4921-4. PubMed ID: 3861238
    [Abstract] [Full Text] [Related]

  • 16. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 17. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
    Tamayo E, Hervé P.
    Exp Hematol; 1988 Feb 15; 16(2):97-101. PubMed ID: 3276544
    [Abstract] [Full Text] [Related]

  • 18. Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo.
    Teicher BA, Holden SA, Cucchi CA, Cathcart KN, Korbut TT, Flatow JL, Frei E.
    Cancer Res; 1988 Jan 01; 48(1):94-100. PubMed ID: 3121169
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia.
    Skala JP, Rogers PC, Chan KW, Rodriguez WC.
    Prog Clin Biol Res; 1992 Jan 01; 377():57-62. PubMed ID: 1332075
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.